Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019.

ABSTRACT:

Objective

Liver cancer is the world's sixth most prevalent cancer and the third most frequent cause of cancer-related mortality. Glucose metabolic disorders, indicated by a high fasting plasma glucose (HFPG) concentration, is a contributor to the etiology of liver cancer. With the rising prevalence of glucose metabolic disorders, an assessment of the global burden of liver cancer attributable to HFPG is warranted to inform global liver cancer prevention and control strategies.

Methods and analysis

We evaluated the global death and disability-adjusted life years (DALYs) of liver cancer and its subtypes attributable to HFPG at global, regional, and country level. The temporal trend and disparity across geographic regions, social development level, age groups and sex were asses

SUBMITTER: Wang M 

PROVIDER: S-EPMC12275694 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature